Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

Y. Oki, D. Buglio, J. Zhang, Y. Ying, S. Zhou, A. Sureda, D. Ben-Yehuda, P. L. Zinzani, H. M. Prince, S. J. Harrison, M. Kirschbaum, P. B. Johnston, A. Shen, B. Von Tresckow, A. Younes

Research output: Contribution to journalLetter

30 Scopus citations
Original languageEnglish (US)
Article numbere236
JournalBlood cancer journal
Volume4
Issue number8
DOIs
StatePublished - Aug 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Oki, Y., Buglio, D., Zhang, J., Ying, Y., Zhou, S., Sureda, A., Ben-Yehuda, D., Zinzani, P. L., Prince, H. M., Harrison, S. J., Kirschbaum, M., Johnston, P. B., Shen, A., Von Tresckow, B., & Younes, A. (2014). Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression. Blood cancer journal, 4(8), [e236]. https://doi.org/10.1038/bcj.2014.58p